KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to -$49.3 million.

  • BeOne Medicines' Cash from Investing Activities rose 6319.59% to -$49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$331.4 million, marking a year-over-year increase of 3593.54%. This contributed to the annual value of -$548.4 million for FY2024, which is 101385.57% down from last year.
  • As of Q3 2025, BeOne Medicines' Cash from Investing Activities stood at -$49.3 million, which was up 6319.59% from -$66.6 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Cash from Investing Activities registered a high of $658.7 million during Q2 2022, and its lowest value of -$209.8 million during Q1 2024.
  • Its 5-year average for Cash from Investing Activities is $45.3 million, with a median of -$21.2 million in 2021.
  • In the last 5 years, BeOne Medicines' Cash from Investing Activities surged by 151295.54% in 2022 and then crashed by 26376.4% in 2024.
  • BeOne Medicines' Cash from Investing Activities (Quarter) stood at -$21.2 million in 2021, then skyrocketed by 281.68% to $38.5 million in 2022, then plummeted by 262.4% to -$62.6 million in 2023, then plummeted by 49.57% to -$93.6 million in 2024, then skyrocketed by 47.36% to -$49.3 million in 2025.
  • Its Cash from Investing Activities was -$49.3 million in Q3 2025, compared to -$66.6 million in Q2 2025 and -$121.9 million in Q1 2025.